Search research articles
Contact Us
Filters
Showing results (21-30 of 198) with videos related to
Page
of 20
Sort By:
The American Journal of Cardiology
|
April 25, 1986
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors
K A Neve, P B Molinoff
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1977
Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme
J C Orcutt, P B Molinoff
Biochemical Pharmacology
|
May 15, 1976
Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs
J C Orcutt, P B Molinoff
Molecular Pharmacology
|
September 1, 1992
Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists
C D Unsworth, P B Molinoff
Biochemical Pharmacology
|
May 15, 1980
Classification and quantitation of beta-adrenergic receptor subtypes
K P Minneman, P B Molinoff
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation
B J Ebersole, P B Molinoff
Journal of Neurochemistry
|
January 1, 1972
Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity
D J Reis, P B Molinoff
Behavioural Brain Research
|
January 1, 1996
Regulation of 5-HT2A receptor mRNA in P11 cells
R C Ferry, P B Molinoff
Molecular Pharmacology
|
March 1, 1983
Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum
N R Zahniser, P B Molinoff
Journal of Neurochemistry
|
April 1, 1992
Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers
B J Ebersole, P B Molinoff
Page
of 20
Search research articles
Search
Showing results (21-30 of 198) with videos related to
Sort By:
Page
of 20
The American Journal of Cardiology
|
April 25, 1986
Effects of chronic administration of agonists and antagonists on the density of beta-adrenergic receptors
K A Neve, P B Molinoff
The Journal of Pharmacology and Experimental Therapeutics
|
September 1, 1977
Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme
J C Orcutt, P B Molinoff
Biochemical Pharmacology
|
May 15, 1976
Endogenous inhibitors of dopamine-beta- hydroxylase in rat organs
J C Orcutt, P B Molinoff
Molecular Pharmacology
|
September 1, 1992
Regulation of the 5-hydroxytryptamine1B receptor in opossum kidney cells after exposure to agonists
C D Unsworth, P B Molinoff
Biochemical Pharmacology
|
May 15, 1980
Classification and quantitation of beta-adrenergic receptor subtypes
K P Minneman, P B Molinoff
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1991
Inhibition of binding of [3H]PN200-110 to membranes from rat brain and heart by ascorbate is mediated by lipid peroxidation
B J Ebersole, P B Molinoff
Journal of Neurochemistry
|
January 1, 1972
Brain dopamine- -hydroxylase: regional distribution and effects of lesions and 6-hydroxy-dopamine on activity
D J Reis, P B Molinoff
Behavioural Brain Research
|
January 1, 1996
Regulation of 5-HT2A receptor mRNA in P11 cells
R C Ferry, P B Molinoff
Molecular Pharmacology
|
March 1, 1983
Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum
N R Zahniser, P B Molinoff
Journal of Neurochemistry
|
April 1, 1992
Identification of ascorbate as an endogenous substance that irreversibly inhibits binding of dihydropyridine calcium channel blockers
B J Ebersole, P B Molinoff
Page
of 20